Department of Neurology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China.
Front Immunol. 2020 Dec 9;11:595417. doi: 10.3389/fimmu.2020.595417. eCollection 2020.
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder mediated by NMDAR antibodies, typically manifesting as behavioral complaints, psychosis, seizures, movement disorders, hypoventilation, and autonomic dysfunction. In recent years, the predisposing factors and pathophysiological mechanisms of anti-NMDAR encephalitis have been tried to be clarified. It has been recognized that an overlap may be observed between anti-NMDAR encephalitis and inflammatory demyelinating disease. However, anti-NMDAR encephalitis is rarely associated with multiple sclerosis. Here, we describe a Chinese female patient diagnosed with relapsing remitting multiple sclerosis who developed anti-NMDAR encephalitis. Further, we discuss the previously reported literature.
抗 N-甲基-D-天冬氨酸受体(NMDAR)脑炎是一种由 NMDAR 抗体介导的自身免疫性疾病,通常表现为行为异常、精神病、癫痫发作、运动障碍、通气不足和自主神经功能障碍。近年来,抗 NMDAR 脑炎的易感因素和病理生理机制已被尝试阐明。人们已经认识到,抗 NMDAR 脑炎和炎症性脱髓鞘疾病之间可能存在重叠。然而,抗 NMDAR 脑炎很少与多发性硬化症相关。在此,我们描述了一位被诊断为复发缓解型多发性硬化症的中国女性患者,其发生了抗 NMDAR 脑炎。此外,我们还讨论了之前报道的文献。